GSG Advisors LLC Acquires Shares of 6,005 Astera Labs, Inc. $ALAB

GSG Advisors LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, Holdings Channel.com reports. The institutional investor bought 6,005 shares of the company’s stock, valued at approximately $2,901,000. Astera Labs accounts for approximately 0.6% of GSG Advisors LLC’s portfolio, making the stock its 25th largest holding.

Other institutional investors and hedge funds have also made changes to their positions in the company. Reflection Asset Management purchased a new stake in shares of Astera Labs in the fourth quarter valued at approximately $25,000. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs in the second quarter valued at approximately $25,000. Smartleaf Asset Management LLC increased its holdings in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in Astera Labs during the fourth quarter worth approximately $33,000. Finally, Whipplewood Advisors LLC lifted its position in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after buying an additional 319 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on ALAB shares. Citigroup reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Roth Capital reiterated a “buy” rating and set a $450.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Susquehanna boosted their price target on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Royal Bank Of Canada boosted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Finally, Morgan Stanley upped their price objective on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $333.00.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the transaction, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 419,244 shares of company stock worth $163,135,169. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

ALAB stock opened at $284.97 on Monday. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The firm has a market cap of $49.44 billion, a PE ratio of 141.07 and a beta of 3.84. The firm’s 50 day moving average price is $352.70 and its 200-day moving average price is $245.57.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.